share_log
Reuters ·  May 2 16:00
Ultragenyx Pharmaceutical Inc - Reaffirmed 2024 Expected Total Revenue Guidance Between $500 Mln to $530 Mln
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment